Videos
August 18, 2022

Dr. Malaz Boustani on stopping the connection between delirium and dementia

Dr. Malaz Boustani on stopping the connection between delirium and dementia

With new funding, Dr. Malaz Boustani and co-researchers will study patients who experienced delirium following emergency general surgery to see if a collaborative care model can mitigate patients’ increased risk for Alzheimer’s disease and related dementias.

Read the full release

 

Transcript: 

For the past 20 years, I’ve been obsessed with the relationship between delirium and Alzheimer’s disease. In our lab over here at IU, with other labs across the country, identified delirium as a modifiable risk factor for the future development of Alzheimer’s disease and other related dementia. In the same time, we developed and tested and deployed a collaborative care model for patients living with Alzheimer’s disease and other related dementia. We took that collaborative care model and we started testing it in other populations. We thought how about if we see if the collaborative care model can actually help in the cognitive, functional and psychological recovery of delirium survivors, and specifically those delirium survivors after emergent surgery.

Related News

image of pregnant woman with vaccine acting as protection from COVID virus

National CDC-funded study confirms that mRNA vaccines protect against serious COVID-19 during pregnancy

The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two

Thomas Imperiale

Journal editorial: Regenstrief researcher calls for tailoring colorectal cancer screening for 45-to-49-year-olds

It’s been a year since national recommendations issued by the American Cancer Society and the U.S. Multi-Society Task Force

Dr. Shaun Grannis on data surveillance of post-COVID conditions

Dr. Shaun Grannis on data surveillance of post-COVID conditions

Regenstrief Vice President for Data and Analytics Shaun Grannis, M.D., M.S., discusses the questions that will be investigated in

Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

Widely used scales measure pain, depression, anxiety, suicide risk, cancer fatigue and now symptoms associated with a common dental